Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
34,672,382
-
Shares change
-
+1,171,979
-
Total reported value, excl. options
-
$321,430,455
-
Value change
-
+$7,599,744
-
Put/Call ratio
-
100%
-
Number of buys
-
52
-
Number of sells
-
63
-
Price
-
$9.27
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q1 2024
As of 31 Mar 2024 Pulmonx Corp - COM (LUNG) had 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,672,382 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, FMR LLC, BlackRock Inc., Point72 Asset Management, L.P., MORGAN STANLEY, VANGUARD GROUP INC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and VICTORY CAPITAL MANAGEMENT INC.
This table shows 117 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.